Atossa Therapeutics has closed a registered direct offering, securing approximately $4.5 million in gross proceeds from the sale of common shares and warrants. The offering also provides the potential for an additional $12 million if all Series Warrants are fully exercised. The company plans to dedicate these funds to clinical development of its product candidates, working capital, and general corporate activities.

Allegro Microsystems Inc (ALGM) shares surged 5.1% to $50.41, showing a 91.1% increase year-to-date. Despite this performance, the stock is considered "Significantly Overvalued" with a GF Value™ estimate of $29.07, indicating a 73.4% margin of safety. While its GF Score™ is 82/100, driven by strong growth and momentum, the low valuation rank and insider selling suggest caution for investors.

AudioEye (AEYE) stock fell by 1.33% in its latest trading session, underperforming the broader market despite upcoming positive earnings and revenue growth predictions. The company is anticipated to report a significant rise in EPS and revenue for the current quarter and the full year, but current analyst estimates place it as a Zacks Rank #4 (Sell) with a discounted Forward P/E ratio compared to its industry.

Arista Networks (NYSE: ANET) stock rose over 4% on Friday after Morgan Stanley analyst Meta Marshall increased her price target for the company to $190 from $180 per share, maintaining an overweight rating. Marshall believes Arista Networks is well-positioned to benefit from artificial intelligence implementations moving into the inference stage, which requires more advanced networking equipment. The company is viewed as a strong player in cloud networking and is expected to capitalize on the growing AI market.

Jabil (JBL) shares increased by 2.1% in its latest session, outperforming the S&P 500. The company has seen a 6.36% appreciation over the past month and is set to release its earnings on June 17, 2026, with analysts projecting significant year-over-year growth in both earnings and revenue. Jabil currently holds a Zacks Rank of #2 (Buy) and is considered undervalued compared to its industry based on its Forward P/E and PEG ratios.

West Fraser Timber Co.Ltd (WFG) shares rose 3.2% on June 12, 2026, but the stock is currently trading 2.5% above its GF Value™ of $67.36, indicating slight overvaluation. The company has a GF Score™ of 73/100, suggesting above-average long-term return potential, although its growth prospects are limited. There have been no insider transactions in the last three months, showing a neutral sentiment from executives.

This article compares Home Depot (HD) and Lowe's (LOW) as dividend stock investments, highlighting their business models, financial performance, valuation, and dividend histories. While Home Depot has a higher current dividend yield and larger scale, Lowe's boasts a longer dividend growth streak, making it a Dividend Aristocrat and King, and appears to have a cheaper valuation. Ultimately, the article concludes that both are attractive buys, with Lowe's having a slight edge due to its valuation and dividend history.

Eagle Point Credit Management LLC and Eagle Point DIF GP I LLC, significant owners of ACRES Commercial Realty Corp. (NASDAQ:ACR), sold $61,551 worth of the company's preferred stock between June 10 and June 12, 2026. These transactions involved both Series D and Series C Preferred Stock, with prices ranging from $22.55 to $25.47 per share. Following these sales, Eagle Point entities still indirectly hold substantial amounts of both preferred and common stock, even as ACR's common stock trades near its 52-week low and analysts view it as undervalued.

Delta Air Lines has replaced its 2023 credit facility with a new undrawn $2.65 billion revolving line on June 11, 2026. This new facility, split into three-year and five-year tranches, includes an accordion feature to increase commitments up to $3.65 billion and incorporates stricter coverage covenants. Analysts currently rate DAL stock as a Buy with a $75 price target, while TipRanks' AI Analyst, Spark, rates it as Outperform due to solid financials and attractive valuation.

Dixon Robert L JR, a Director at Elevance Health Inc (ELV), recently sold 151 shares of the company, bringing his total ownership to 10,734 shares. The transaction, on June 11, 2026, saw shares trading at $401.77, with the company currently assessed as modestly undervalued based on its GuruFocus Value of $509.05. The company's P/E ratio of 17.19 is lower than both the industry median and its historical median.